Administration of adjuvant oxaliplatin to patients with stage III colon cancer is affected by age and hospital

Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients

(2013) Jennifer L. Lund et al.   CANCER

Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlands

(2012) L. N. van Steenbergen et al.   ANNALS OF ONCOLOGY

Geographic Variation and Sociodemographic Disparity in the Use of Oxaliplatin-Containing Chemotherapy in Patients With Stage III Colon Cancer

(2012) Janki M. Panchal et al.   Clinical Colorectal Cancer

Adherence to Stage-Specific Treatment Guidelines for Patients With Colon Cancer

(2012) Ryaz Chagpar et al.   JOURNAL OF CLINICAL ONCOLOGY

Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial

(2012) Christophe Tournigand et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of Adjuvant Chemotherapy on Survival of Patients With Stage III Colon Cancer Diagnosed After Age 75 Years

(2012) Hanna K. Sanoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparative Effectiveness of Oxaliplatin vs Non–Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon Cancer

(2012) Hanna K. Sanoff et al.   JNCI-Journal of the National Cancer Institute

Adjuvant chemotherapy in stage III colon cancer: Guideline implementation, patterns of use and outcomes in daily practice in The Netherlands

(2011) Chantal W. M. van Gils et al.   ACTA ONCOLOGICA

Patterns of Adjuvant Chemotherapy Use in a Population-Based Cohort of Patients With Resected Stage II or III Colon Cancer

(2011) Thomas A. Abrams et al.   JOURNAL OF CLINICAL ONCOLOGY

Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

(2011) Greg Yothers et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparative Effectiveness of Different Chemotherapeutic Regimens on Survival of People Aged 66 and Older with Stage III Colon Cancer: A “Real World” Analysis Using Surveillance, Epidemiology, and End Results-Medicare Data

(2011) Fei-Yuan Hsiao et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands

(2009) L. N. van Steenbergen et al.   ANNALS OF ONCOLOGY

Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women

(2009) Dawn L. Hershman et al.   CANCER

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

(2009) Thierry André et al.   JOURNAL OF CLINICAL ONCOLOGY